Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

Iqvia (IQV) announced a strategic collaboration with Nvidia (NVDA) to help realize the potential of AI in healthcare and life sciences. Discover outperforming stocks and invest smarter with Top ...

Feb 6 (Reuters) - Contract research firm IQVIA Holdings (IQV.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare ...

(see more details here). IQVIA Holdings Inc. (NYSE:IQV) is a software and project management company that caters to the needs ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a ...

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life science tools group will likely continue to work ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

How Virtual Clinical Trials Are Speeding The Path To Another Vaccine For decades, IQVIA has been helping pharmaceutical giants perform clinical trials to test new treatments. The company combines ...

(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, life sciences services company IQVIA Holdings Inc. (IQV) initiated its adjusted earnings and revenue guidance for ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...